Skip to main content

Milestone 9.A

Develop and validate translatable biomarkers for their use in preclinical and clinical drug development. These efforts should include the development of pharmacodynamic biomarkers of target engagement, biomarkers of incipient disease (ocular, olfactory) and biomarkers for detection and tracking of synaptic dysfunction.


Success Criteria

  • Develop and validate at least 12 translatable biomarkers for use in preclinical and clinical drug development.


Research Implementation Area
Biomarkers
Timeline
2016–2023
Status
In Progress

Implementation Activities

Funding Initiatives

Research Programs and Resources

Research Highlights

Relevant Recommendations